Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

Cell Reports(2021)10.1016/j.celrep.2021.109992Source: DataRank Database

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 1.6. It has been cited 59 times, with 38 citing works in its 1-hop citation network.

N/A

1.6DataRank · unranked

Scored on demand from live citation data

Open Access59 citations · 38 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (40 grants)Impact (FWCI 3.49)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 39%Citation Network 61%

Base Score Contribution

0.614

From this paper's citation signal

Citation Network Contribution

0.941

From 33 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 38 citers.

Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma
Neuro-Oncology2022144 citations32 referencesContributes 0.156
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade
Nature Communications202491 citations48 referencesContributes 0.094
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study
Bone Marrow Transplantation202323 citations39 referencesContributes 0.081
In the Right Place and the Right State: Spatial Cross-Talk and Immune State Dictate Leukemia Response to Immunotherapy
Cancer Research20251 citations10 referencesContributes 0.069
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia
Blood202528 citations58 referencesContributes 0.058

Authors (22)

Elham Azizi ORCID,Cassandra Burdziak ORCID,Vinhkhang N. Nguyen,Christina Ennis ORCID,Katie Maurer ORCID

Live enrichment

PubMed:34758319 PMC:PMC9035342 OpenAlex:https://openalex.org/W3212164957

National Institutes of Health

Grant: 5P30 CA006516

American Cancer Society

Grant: F31CA246901

American Cancer Society

Grant: PF-17-243- 01-RMC

American Society of Hematology

Grant: 1K08CA248458-01

Elucidating human leukemia and T cell interactions within the tumor microenvironment

American Society of Hematology

Grant: K99CA230195

NCI

Grant: 1R01CA155010

NCI

Grant: P01CA206978

NCI

Grant: P01CA229092

NCI

Grant: U10CA180861

NCI

Grant: U24CA224331

Cancer Prevention and Research Institute of Texas

Grant: RR210008

National Cancer Institute

Grant: P30 CA008748

National Cancer Institute

Grant: R50CA251956

National Cancer Institute

Grant: U54CA209975

NCI NIH HHS

Grant: P01 CA066996

NCI NIH HHS

Grant: R00 CA230195

NCI NIH HHS

Grant: P30 CA006516

NCI NIH HHS

Grant: R01 CA155010

NCI NIH HHS

Grant: K08 CA248458

European Commission

Grant: 206978

Lattices in Computer Science

National Institutes of Health

Grant: 5F31CA246901-02

Single Cell Dissection of Epigenetic and Tumor Ecosystem Dynamics During Pancreatic Cancer Progression

National Institutes of Health

Grant: 5R50CA251956-05

Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment

National Institutes of Health

Grant: 5R01CA155010-02

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

National Institutes of Health

Grant: 5K99CA230195-02

Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment

National Institutes of Health

Grant: 5P01CA229092-03

Immune Modulation After Allogeneic HCT

National Institutes of Health

Grant: 3P30CA006516-41S6

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 1U10CA180861-01

ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie

National Institutes of Health

Grant: 5U54CA209975-02

The CSBC Research Center for Cancer Systems Immunology at MSKCC

National Institutes of Health

Grant: 2U24CA224331-02

Cancer Immune Monitoring and Analysis Center

National Institutes of Health

Grant: 5P01CA206978-05

Comprehensive dissection of the CLL genome and phenome to improve patient outcomes

Ludwig Institute for Cancer Research

Gilead Sciences

Neos Therapeutics

Parker Institute for Cancer Immunotherapy

Dana-Farber Cancer Institute

Novartis

Exelixis

Damon Runyon Cancer Research Foundation

G. Harold and Leila Y. Mathers Foundation

Leukemia and Lymphoma Society

FWCI

3.49

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S2211124721014716/pdf

publisherhttp://www.cell.com/article/S2211124721014716/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721014716?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721014716?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2021.109992

Fields of Study

CAR-T cell therapy researchCRISPR and Genetic EngineeringT-cell and B-cell Immunology03 medical and health sciences0302 clinical medicineClonal EvolutionHumansImmunotherapy, AdoptiveLeukemiaLongitudinal StudiesLymphocyte ActivationLymphocyte TransfusionNeoplasm Recurrence, LocalStem Cell TransplantationT-LymphocytesTissue DonorsTransplantation, Homologous

MeSH Terms

HumansLeukemiaLongitudinal StudiesLymphocyte ActivationNeoplasm Recurrence, LocalT-LymphocytesTissue DonorsTransplantation, HomologousImmunotherapy, AdoptiveLymphocyte TransfusionStem Cell TransplantationClonal Evolution

Keywords

Resistance (ecology)Cell therapyBiologyCellComputational biologyGeneticsEcologyLeukemiaImmunotherapyExhaustionGene Regulatory NetworksProbabilistic ModelsDonor Lymphocyte InfusionStatistical Machine LearningAllogeneic Hematopoietic Stem Cell TransplantScrna-seqAtac-seqQH301-705.5T-LymphocytesLymphocyte ActivationImmunotherapy, AdoptiveArticleTissue DonorsClonal EvolutionLymphocyte TransfusionHumansTransplantation, HomologousLongitudinal StudiesBiology (General)Neoplasm Recurrence, LocalStem Cell Transplantation

Sustainable Development Goals

SDG 3: 3. Good health